Cite

    Karpova, D., Bräuninger, S., Wiercinska, E., Krämer, A., Stock, B., Graff, J., Martin, H., Wach, A., Escot, C., Douglas, G., Romagnoli, B., Chevalier, E., Dembowski, K., Hooftman, L., & Bonig, H. (2017). mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers—results of a dose escalation trial. Journal of translational medicine, 15(1), 1–12. http://access.bl.uk/ark:/81055/vdc_100080978682.0x000054